Asthma
Conditions
Interventions
Experimental group:Danlong Oral Liquid 10ml Tid Po based on the standard treatment
Control group:Placebo Liquid 10ml Tid Po based on the standard treatment
Sponsors
Tongde Hospital of Zhejiang Province
Eligibility
Sex/Gender
All
Age
18 Years to 999 Years
Inclusion criteria
Inclusion criteria: Fulfilled the diagnostic criteria for chronic persistent of asthma; Fulfilled the TCM syndrome differentiation criteria for heat syndrome (fullfil three criteria of fever, Red face and red eyes, desire for cold and aversion to heat, yellow urine, dry stool, sticky white or yellow thick phlegm and mucus, red tongue, yellow moss, rapid pulse); Age=18 years; Subjects who agree to participate in this study.
Exclusion criteria
Exclusion criteria: Complicate other chronic airway diseases; Complicate other diseases with wheezing and dyspnea; With other diseases influencing pulmonary function; With other diseases treated with corticosteroid; Complicate severe primary diseases of cardiovascular system, liver, kidney and hematopoietic system; Pregnancy and breast feeding
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Asthma Control Test;pulmonary function;Cumulative dose of inhaled corticosteroid;Cumulative dose of systemic corticosteroid;Blood routine; | — |
Secondary
| Measure | Time frame |
|---|---|
| Renal function;Liver function; | — |
Countries
China
Contacts
Public ContactQian Jin
Tongde Hospital of Zhejiang Province
Outcome results
None listed